News | Angiography | March 10, 2017

Miniature Particle Accelerator Saves on Contrast Agents for Angiography

X-rays from the MuCLS compact synchrotron at Technical University of Munich open up new possibilities for heart examinations

Technical University of Munich, Munich Compact Light Source, MuCLS, angiography, contrast agents

(a) Photograph of the sample in waterbath. (b) Empty image of full MuCLS beam. (c) Quasi-mono-energetic angiography image of a porcine heart acquired at the MuCLS, with iodine-based contrast agent injected into the left coronary artery. Visible are the left anterior descending artery (LAD) and the left circumflex artery (LCX). Image courtesy of the authors.

March 10, 2017 — The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography. For some patients, however, the contrast agents used in this process can cause health problems. A team at the Technical University of Munich (TUM) has now demonstrated that the required quantity of these substances can be significantly reduced if monoenergetic X-rays from a miniature particle accelerator are used.

Soft tissues such as organs and blood vessels are nearly impossible to examine in X-ray images. To detect a narrowing or other changes in coronary blood vessels, patients are therefore usually injected with an iodinated contrast agent.

These substances can sometimes be hazardous to health, however: "Particularly in patients with kidney insufficiency, complications may arise, in some cases even kidney failure," explained Daniela Münzel, M.D., an adjunct teaching professor for radiology at TUM's Klinikum rechts der Isar. "That is why we are studying possibilities of using lower concentrations of contrast agents."

One approach to reducing the dosage has now been developed by scientists from the Department of Diagnostic and Interventional Radiology at the Klinikum rechts der Isar, working in close cooperation with the Chair of Biomedical Physics at TUM's Department of Physics. The method, which they have described in a paper published in Nature Scientific Reports, is not based on new contrast agents. Instead it relies on special X-rays generated using the Munich Compact Light Source (MuCLS), the world's first mini-synchrotron, which was officially inaugurated at TUM at the end of 2015.

"Conventional X-ray sources generate a relatively broad range of energy levels. By contrast, the energy of X-rays produced by the MuCLS can be controlled much more precisely," said physicist Elena Eggl, the first author of the paper.

Contrast agents such as iodine and gadolinium have an absorption edge. That means that when the substance is exposed to X-rays of a certain energy, the contrast of the final image of the marked organ is particularly good. Below the absorption edge — about 30 kiloelectron volts (keV) for iodine — the contrast deteriorates rapidly. The contrast also becomes weaker at energies far above the absorption edge.

As a result, when using conventional broad-spectrum X-ray sources, an adequate quantity of contrast agent must always be used in order to offset this effect and obtain a sufficiently sharp image for a diagnosis. The MuCLS can generate X-rays that have exactly the optimal energy level. The capability of producing such monoenergetic X-rays has existed for some time. In the past, however, this was possible only with circular particle accelerators with a diameter of several hundred meters. In contrast, the MuCLS is comparable in size to a car.

The data shows that monoenergetic X-rays would make it possible to decrease the required concentration of iodine by about one third with no loss of contrast. For gadolinium, there would even be a somewhat greater reduction. A lot more research is needed, however, before real patients can be examined with monoenergetic X-rays.

"We're still at the very beginning of the development of this technology," said Eggl. The MuCLS is the very first machine of its kind. Moreover, it is designed for fundamental research, and not for examining patients. But with detailed computer simulations and tests with a pig's heart, using blood vessels dyed with iodine, the researchers were able to demonstrate feasibility of the method.

Franz Pfeiffer, professor of biomedical physics at TUM, sees the team's results as a promising start for medical research with the compact synchrotron: "The MuCLS offers numerous possibilities for medical applications that we plan to continue researching with our partners in medical fields,” he said.

The research was funded by the German Research Foundation (DFG), Munich-Centre for Advanced Photonics (MAP) cluster of excellence, the Center for Advanced Laser Applications (CALA), the Ministry for Education and Research, and the DFG Gottfried Wilhelm Leibniz Program.

For more information: www.nature.com/srep

References
Eggl E.,  Mechlem K., Braig E., Kulpe S., et al. "Mono-Energy Coronary Angiography with a Compact Synchrotron Source". Scientific Reports. Published online Feb. 9, 2017. DOI:10.1038/srep42211

Related Content

Osprey Medical and GE Healthcare Launch Acute Kidney Injury Educational Program
News | Angiography | September 25, 2018
September 21, 2018 — Osprey Medical announced a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys campa
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cardiac Imaging | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
LVivo EF Cardiac Tool Now Available for GE Vscan Extend Handheld Mobile Ultrasound
Technology | Cardiovascular Ultrasound | September 19, 2018
DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound analysis tools,...
Siemens Healthineers Announces First U.S. Install of Somatom go.Top CT
News | Computed Tomography (CT) | September 17, 2018
September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare
Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | September 12, 2018
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore co
The Siemens Biograph Vision PET-CT system was released in mid-2018.

The Siemens Biograph Vision PET-CT system was released in mid-2018.

Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography...

Image courtesy of Siemens Healthineers

Feature | CT Angiography (CTA) | September 06, 2018 | Dave Fornell
There have been a few big, recent advancements in cardiac computed tomography angiography (CCTA) imaging technology....
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
Scientists Develop New MRI Tool for Cancer Diagnosis and Therapy

Researchers in the laboratory ‘Biomedical Nanomaterials’ of NUST MISIS. Image courtesy of PR Newsfoto/NUST MISIS.

News | Oncology Diagnostics | August 24, 2018
A European research group has developed a system that allows doctors to both improve the accuracy of diagnosing...
Philips Launches Epiq CVx and CVxi Cardiovascular Ultrasound Systems
Technology | Cardiovascular Ultrasound | August 22, 2018
Philips recently announced the introduction of the Epiq CVx cardiovascular ultrasound system. Built on the Epiq...